Petroteq Energy Announces that Production of Oil from the POSP has Recommenced
SHERMAN OAKS, CA / ACCESSWIRE / May 27, 2021 / Petroteq Energy Inc. (“Petroteq” or…
Month: May 2021
Gamesys Group PLC Announces Director/PDMR Shareholding
LONDON, UK / ACCESSWIRE / May 27, 2021 / Gamesys Group plc (LSE:GYS) (the “Company“), announces…
Gamesys Group PLC Announces Director/PDMR Shareholding
LONDON, UK / ACCESSWIRE / May 27, 2021 / Gamesys Group plc (LSE:GYS) (the “Company“), announces…
UKCloud supports ‘Build Back Better’ with significant investment in jobs, skills and infrastructure
UKCloud strengthens its commitment to supporting Britain’s technology led economic recovery London – 27th May…
Time Matters: Companies Prioritizing Investments That Reduce Time-To-Value From Data
Growth strategy, customer expectations and competitive pressures are key drivers of investments in real-time data…
AFFiRiS: Positive phase 1 results with immunotherapies targeting PCSK9 to treat hypercholesterolemia published by the European Journal of Clinical Pharmacology
Repeated immunization with AFFITOPE® peptide active immunotherapy candidates AT04A and AT06A is safe, well-tolerated and…
VAXIMM to Attend International Scientific and Industry Events
BASEL, Switzerland and MANNHEIM, Germany, May 27, 2021 (GLOBE NEWSWIRE) — VAXIMM AG, a Swiss/German…
Disclosure of voting rights for Chairman of the Board
Oslo, 27 May 2021. PCI Biotech Holding ASA (“PCI Biotech” or the “Company”) issue this…
Pulmocide Raises $92 million in a Series C Financing to Fund Registration Program for PC945
Pulmocide Raises $92 million in a Series C Financing to Fund Registration Program for PC945…
Bavarian Nordic Launches Share Buy-Back Program to Hedge Incentive Scheme Obligations
COPENHAGEN, Denmark, May 27, 2021 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today…
Bavarian Nordic Announces Interim Results for the First Three Months of 2021
COPENHAGEN, Denmark, May 27, 2021 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today…
Sanofi and GSK initiate global Phase 3 clinical efficacy study of COVID-19 vaccine candidate
Sanofi and GSK initiate global Phase 3 clinical efficacy study of COVID-19 vaccine candidate Two-stage…
Bavarian Nordic Announces Marketing and Distribution Agreement with Dynavax to Launch HEPLISAV B® Hepatitis B Vaccine in Germany
COPENHAGEN, Denmark, May 27 2021 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) has entered…
Novartis and Molecular Partners announce start of EMPATHY clinical trial for ensovibep for the treatment of COVID-19
EMPATHY global multi-center Phase 2 – 3 study, recruiting patients with COVID-19 infection, aiming to…
Santhera Publishes Agenda for its Annual General Meeting
Pratteln, Switzerland, May 27, 2021 – Santhera Pharmaceuticals (SIX: SANN) announces the invitation to its Annual…
Day One Announces Pricing of Upsized Initial Public Offering
SOUTH SAN FRANCISCO, Calif., May 26, 2021 (GLOBE NEWSWIRE) — Day One Biopharmaceuticals, Inc. (Nasdaq:…
Reviva Announces Pricing of Upsized $30 Million Underwritten Public Offering
CUPERTINO, Calif., May 26, 2021 (GLOBE NEWSWIRE) — Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva”…
Ocugen On Track to Submit Emergency Use Authorization Application to U.S. FDA for its COVID-19 Vaccine Candidate, COVAXIN™
Active discussions with FDA related to COVAXIN initiated late last year Master file submitted to…
Scopus BioPharma to Reschedule 2021 Annual Meeting of Shareholders
NEW YORK, May 26, 2021 (GLOBE NEWSWIRE) — Scopus BioPharma Inc. (Nasdaq: “SCPS”) today announced…
GSK and Vir Biotechnology Announce Sotrovimab (VIR-7831) Receives Emergency Use Authorization from the US FDA for Treatment of Mild-to-Moderate COVID-19 in High-Risk Adults and Pediatric Patients
– Treatment with sotrovimab resulted in an 85% reduction in the risk of hospitalization or…